Superficial X-ray viable for basal, squamous cell carcinoma

August 6, 2012
Superficial X-ray viable for basal, squamous cell carcinoma
Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma and squamous cell carcinoma in select patients, according to a study published online July 23 in the Journal of the American Academy of Dermatology.

(HealthDay) -- Superficial X-ray therapy remains a viable treatment for primary basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in select patients, according to a study published online July 23 in the Journal of the American Academy of Dermatology.

To examine the efficacy and viability of superficial X-ray therapy in the treatment of BCC and SCC, Armand B. Cognetta, M.D., from Dermatology Associates of Tallahassee in Florida, and colleagues conducted a retrospective analysis of 1,715 histologically confirmed primary cutaneous BCC and SCC among outpatients seen between 2000 and 2010. All tumors were treated with superficial X-ray therapy.

Of the tumors reviewed, the researchers found that 712 were histologically proven BCC (631 nodular and 81 superficial), 994 were SCC, and nine displayed features of both BCC and SCC. At two and five years, the cumulative recurrence rates were 1.9 and 5.0 percent, respectively, for all tumors; 2.0 and 4.2 percent, respectively, for all BCC; and 1.8 and 5.8 percent, respectively, for all SCC. There was a significantly increased likelihood of recurrence for tumors on male patients and tumors with a diameter greater than 2 cm.

"Superficial X-ray therapy remains a viable nonsurgical option for the treatment of primary BCC and SCC in patients where surgical intervention is declined, unadvisable, or potentially associated with significant cosmetic or ," the authors write.

One author disclosed financial ties to Sensus Health Care.

Explore further: Basal cell carcinoma on ear significantly more aggressive

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Basal cell carcinoma on ear significantly more aggressive

April 18, 2012
(HealthDay) -- Basal cell carcinoma (BCC) on the ear is significantly more likely to be aggressive, and occurs more frequently in men, according to a study published in the May issue of the Journal of the American Academy ...

Researchers find smoking is strongly associated with squamous cell carcinoma among women

December 8, 2011
Women who have non-melanoma skin cancers are more likely to have smoked cigarettes compared to women without skin cancer, said researchers at Moffitt Cancer Center in Tampa, Fla., who published study results in a recent issue ...

Study finds psoriasis treatment increases skin cancer risk

March 29, 2012
(HealthDay) -- The long-term risk of squamous cell carcinoma (SCC) is significantly increased for patients with severe psoriasis who receive more than 350 psoralen and ultraviolet A (PUVA) treatments compared with those who ...

Coffee consumption associated with decreased risk for basal cell carcinoma

October 24, 2011
Caffeine could be related to an inverse association between basal cell carcinoma risk and consumption of coffee, a study found.

Vitamin D levels appear to be associated with risk of skin cancer, although relationship is complex

August 15, 2011
As an individual's level of vitamin D increases, the risk of nonmelanoma skin cancer (NMSC) seems to increase as well, although factors such as ultraviolet (UV) radiation exposure may complicate the relationship, according ...

Sun exposure and cutaneous HPV infection found synergistic in skin cancers

June 25, 2012
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and the German Cancer Research Center in Heidelberg have found that having antibodies for cutaneous types of human papillomavirus (HPV), ...

Recommended for you

Vitamin C may encourage blood cancer stem cells to die

August 17, 2017
Vitamin C may "tell" faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone ...

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.